Intrinsic value of Acadia Healthcare - ACHC

Previous Close

$36.01

  Intrinsic Value

$56.28

stock screener

  Rating & Target

str. buy

+56%

Previous close

$36.01

 
Intrinsic value

$56.28

 
Up/down potential

+56%

 
Rating

str. buy

We calculate the intrinsic value of ACHC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 3.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  7.00
  6.80
  6.62
  6.46
  6.31
  6.18
  6.06
  5.96
  5.86
  5.77
  5.70
  5.63
  5.56
  5.51
  5.46
  5.41
  5.37
  5.33
  5.30
  5.27
  5.24
  5.22
  5.20
  5.18
  5.16
  5.14
  5.13
  5.12
  5.10
  5.09
Revenue, $m
  3,035
  3,241
  3,456
  3,679
  3,911
  4,153
  4,405
  4,667
  4,941
  5,226
  5,524
  5,835
  6,159
  6,499
  6,853
  7,224
  7,612
  8,018
  8,443
  8,888
  9,354
  9,842
  10,354
  10,890
  11,451
  12,041
  12,658
  13,306
  13,985
  14,697
Variable operating expenses, $m
  1,021
  1,071
  1,123
  1,178
  1,234
  1,293
  1,354
  1,418
  1,484
  1,553
  1,342
  1,417
  1,496
  1,579
  1,665
  1,755
  1,849
  1,948
  2,051
  2,159
  2,272
  2,391
  2,515
  2,645
  2,782
  2,925
  3,075
  3,232
  3,397
  3,570
Fixed operating expenses, $m
  1,515
  1,548
  1,582
  1,617
  1,652
  1,689
  1,726
  1,764
  1,803
  1,842
  1,883
  1,924
  1,967
  2,010
  2,054
  2,099
  2,145
  2,193
  2,241
  2,290
  2,341
  2,392
  2,445
  2,498
  2,553
  2,610
  2,667
  2,726
  2,786
  2,847
Total operating expenses, $m
  2,536
  2,619
  2,705
  2,795
  2,886
  2,982
  3,080
  3,182
  3,287
  3,395
  3,225
  3,341
  3,463
  3,589
  3,719
  3,854
  3,994
  4,141
  4,292
  4,449
  4,613
  4,783
  4,960
  5,143
  5,335
  5,535
  5,742
  5,958
  6,183
  6,417
Operating income, $m
  499
  622
  750
  885
  1,025
  1,172
  1,325
  1,486
  1,654
  1,830
  2,299
  2,493
  2,696
  2,910
  3,134
  3,370
  3,617
  3,878
  4,151
  4,439
  4,741
  5,059
  5,394
  5,746
  6,116
  6,506
  6,916
  7,348
  7,802
  8,280
EBITDA, $m
  936
  1,069
  1,208
  1,353
  1,505
  1,664
  1,830
  2,004
  2,186
  2,377
  2,577
  2,786
  3,006
  3,237
  3,479
  3,733
  4,000
  4,281
  4,576
  4,885
  5,211
  5,554
  5,914
  6,293
  6,692
  7,111
  7,552
  8,017
  8,505
  9,019
Interest expense (income), $m
  161
  175
  190
  205
  221
  237
  254
  272
  291
  310
  330
  351
  373
  396
  419
  444
  470
  498
  526
  556
  587
  620
  654
  690
  728
  767
  808
  852
  897
  945
  994
Earnings before tax, $m
  324
  432
  545
  664
  788
  917
  1,053
  1,195
  1,344
  1,500
  1,948
  2,120
  2,301
  2,491
  2,690
  2,899
  3,120
  3,351
  3,595
  3,851
  4,121
  4,405
  4,704
  5,018
  5,349
  5,698
  6,065
  6,451
  6,858
  7,286
Tax expense, $m
  88
  117
  147
  179
  213
  248
  284
  323
  363
  405
  526
  572
  621
  672
  726
  783
  842
  905
  971
  1,040
  1,113
  1,189
  1,270
  1,355
  1,444
  1,538
  1,637
  1,742
  1,852
  1,967
Net income, $m
  237
  315
  398
  485
  575
  670
  769
  872
  981
  1,095
  1,422
  1,548
  1,680
  1,818
  1,964
  2,117
  2,277
  2,447
  2,624
  2,812
  3,008
  3,216
  3,434
  3,663
  3,905
  4,159
  4,427
  4,709
  5,006
  5,319

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,882
  7,350
  7,836
  8,342
  8,869
  9,417
  9,988
  10,583
  11,203
  11,850
  12,525
  13,230
  13,967
  14,736
  15,540
  16,381
  17,261
  18,181
  19,145
  20,154
  21,211
  22,318
  23,478
  24,693
  25,967
  27,303
  28,703
  30,172
  31,712
  33,327
Adjusted assets (=assets-cash), $m
  6,882
  7,350
  7,836
  8,342
  8,869
  9,417
  9,988
  10,583
  11,203
  11,850
  12,525
  13,230
  13,967
  14,736
  15,540
  16,381
  17,261
  18,181
  19,145
  20,154
  21,211
  22,318
  23,478
  24,693
  25,967
  27,303
  28,703
  30,172
  31,712
  33,327
Revenue / Adjusted assets
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
Average production assets, $m
  4,577
  4,888
  5,211
  5,548
  5,898
  6,263
  6,642
  7,038
  7,450
  7,881
  8,330
  8,799
  9,288
  9,800
  10,335
  10,894
  11,479
  12,091
  12,732
  13,403
  14,106
  14,842
  15,613
  16,422
  17,269
  18,157
  19,088
  20,065
  21,089
  22,164
Working capital, $m
  67
  71
  76
  81
  86
  91
  97
  103
  109
  115
  122
  128
  136
  143
  151
  159
  167
  176
  186
  196
  206
  217
  228
  240
  252
  265
  278
  293
  308
  323
Total debt, $m
  3,517
  3,798
  4,090
  4,394
  4,710
  5,039
  5,381
  5,738
  6,110
  6,498
  6,903
  7,326
  7,768
  8,230
  8,712
  9,217
  9,745
  10,297
  10,875
  11,481
  12,115
  12,779
  13,475
  14,204
  14,969
  15,770
  16,610
  17,491
  18,415
  19,385
Total liabilities, $m
  4,129
  4,410
  4,702
  5,005
  5,321
  5,650
  5,993
  6,350
  6,722
  7,110
  7,515
  7,938
  8,380
  8,842
  9,324
  9,829
  10,356
  10,909
  11,487
  12,092
  12,726
  13,391
  14,087
  14,816
  15,580
  16,382
  17,222
  18,103
  19,027
  19,996
Total equity, $m
  2,753
  2,940
  3,135
  3,337
  3,548
  3,767
  3,995
  4,233
  4,481
  4,740
  5,010
  5,292
  5,587
  5,894
  6,216
  6,552
  6,904
  7,273
  7,658
  8,062
  8,484
  8,927
  9,391
  9,877
  10,387
  10,921
  11,481
  12,069
  12,685
  13,331
Total liabilities and equity, $m
  6,882
  7,350
  7,837
  8,342
  8,869
  9,417
  9,988
  10,583
  11,203
  11,850
  12,525
  13,230
  13,967
  14,736
  15,540
  16,381
  17,260
  18,182
  19,145
  20,154
  21,210
  22,318
  23,478
  24,693
  25,967
  27,303
  28,703
  30,172
  31,712
  33,327
Debt-to-equity ratio
  1.280
  1.290
  1.300
  1.320
  1.330
  1.340
  1.350
  1.360
  1.360
  1.370
  1.380
  1.380
  1.390
  1.400
  1.400
  1.410
  1.410
  1.420
  1.420
  1.420
  1.430
  1.430
  1.430
  1.440
  1.440
  1.440
  1.450
  1.450
  1.450
  1.450
Adjusted equity ratio
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400
  0.400

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  237
  315
  398
  485
  575
  670
  769
  872
  981
  1,095
  1,422
  1,548
  1,680
  1,818
  1,964
  2,117
  2,277
  2,447
  2,624
  2,812
  3,008
  3,216
  3,434
  3,663
  3,905
  4,159
  4,427
  4,709
  5,006
  5,319
Depreciation, amort., depletion, $m
  436
  447
  458
  469
  480
  493
  505
  518
  532
  547
  278
  293
  310
  327
  344
  363
  383
  403
  424
  447
  470
  495
  520
  547
  576
  605
  636
  669
  703
  739
Funds from operations, $m
  673
  762
  856
  953
  1,055
  1,162
  1,274
  1,391
  1,513
  1,642
  1,700
  1,841
  1,989
  2,145
  2,308
  2,480
  2,660
  2,850
  3,049
  3,258
  3,479
  3,710
  3,954
  4,211
  4,481
  4,765
  5,063
  5,378
  5,709
  6,057
Change in working capital, $m
  4
  5
  5
  5
  5
  5
  6
  6
  6
  6
  7
  7
  7
  7
  8
  8
  9
  9
  9
  10
  10
  11
  11
  12
  12
  13
  14
  14
  15
  16
Cash from operations, $m
  669
  758
  851
  948
  1,050
  1,157
  1,268
  1,385
  1,507
  1,636
  1,693
  1,834
  1,982
  2,137
  2,300
  2,472
  2,652
  2,841
  3,039
  3,249
  3,468
  3,700
  3,943
  4,199
  4,468
  4,752
  5,050
  5,364
  5,694
  6,042
Maintenance CAPEX, $m
  -143
  -153
  -163
  -174
  -185
  -197
  -209
  -221
  -235
  -248
  -263
  -278
  -293
  -310
  -327
  -344
  -363
  -383
  -403
  -424
  -447
  -470
  -495
  -520
  -547
  -576
  -605
  -636
  -669
  -703
New CAPEX, $m
  -300
  -311
  -324
  -337
  -350
  -365
  -380
  -396
  -412
  -430
  -449
  -469
  -490
  -512
  -535
  -559
  -585
  -612
  -641
  -671
  -703
  -736
  -771
  -808
  -847
  -888
  -931
  -977
  -1,024
  -1,074
Cash from investing activities, $m
  -443
  -464
  -487
  -511
  -535
  -562
  -589
  -617
  -647
  -678
  -712
  -747
  -783
  -822
  -862
  -903
  -948
  -995
  -1,044
  -1,095
  -1,150
  -1,206
  -1,266
  -1,328
  -1,394
  -1,464
  -1,536
  -1,613
  -1,693
  -1,777
Free cash flow, $m
  226
  294
  364
  438
  515
  596
  680
  768
  860
  957
  982
  1,088
  1,199
  1,316
  1,439
  1,568
  1,703
  1,846
  1,996
  2,153
  2,319
  2,493
  2,677
  2,870
  3,074
  3,288
  3,513
  3,751
  4,001
  4,264
Issuance/(repayment) of debt, $m
  277
  281
  292
  304
  316
  329
  343
  357
  372
  388
  405
  423
  442
  462
  483
  505
  528
  552
  578
  605
  634
  664
  696
  729
  764
  801
  840
  881
  924
  969
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  277
  281
  292
  304
  316
  329
  343
  357
  372
  388
  405
  423
  442
  462
  483
  505
  528
  552
  578
  605
  634
  664
  696
  729
  764
  801
  840
  881
  924
  969
Total cash flow (excl. dividends), $m
  504
  575
  656
  742
  831
  925
  1,022
  1,125
  1,232
  1,345
  1,387
  1,511
  1,641
  1,778
  1,921
  2,072
  2,231
  2,398
  2,574
  2,759
  2,953
  3,157
  3,373
  3,599
  3,838
  4,089
  4,354
  4,632
  4,925
  5,234
Retained Cash Flow (-), $m
  -180
  -187
  -195
  -202
  -211
  -219
  -228
  -238
  -248
  -259
  -270
  -282
  -294
  -308
  -322
  -336
  -352
  -368
  -385
  -404
  -423
  -443
  -464
  -486
  -510
  -534
  -560
  -587
  -616
  -646
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  324
  388
  462
  539
  621
  705
  794
  887
  984
  1,086
  1,117
  1,229
  1,346
  1,470
  1,600
  1,736
  1,879
  2,030
  2,188
  2,355
  2,530
  2,715
  2,909
  3,113
  3,328
  3,555
  3,793
  4,045
  4,309
  4,587
Discount rate, %
  8.70
  9.14
  9.59
  10.07
  10.57
  11.10
  11.66
  12.24
  12.85
  13.50
  14.17
  14.88
  15.62
  16.41
  17.23
  18.09
  18.99
  19.94
  20.94
  21.98
  23.08
  24.24
  25.45
  26.72
  28.06
  29.46
  30.93
  32.48
  34.11
  35.81
PV of cash for distribution, $m
  298
  325
  351
  367
  375
  375
  367
  352
  332
  306
  260
  233
  204
  175
  147
  121
  98
  77
  59
  44
  32
  23
  16
  11
  7
  4
  3
  2
  1
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.

FINANCIAL RATIOS  of  Acadia Healthcare (ACHC)

Valuation Ratios
P/E Ratio 520.3
Price to Sales 1.1
Price to Book 1.4
Price to Tangible Book
Price to Cash Flow 8.6
Price to Free Cash Flow 240.1
Growth Rates
Sales Growth Rate 56.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 14.9%
Cap. Spend. - 3 Yr. Gr. Rate 35.2%
Financial Strength
Quick Ratio 2
Current Ratio 0.1
LT Debt to Equity 150%
Total Debt to Equity 151.7%
Interest Coverage 1
Management Effectiveness
Return On Assets 0.5%
Ret/ On Assets - 3 Yr. Avg. 4%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. 3.1%
Return On Equity 0.3%
Return On Equity - 3 Yr. Avg. 7.1%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 11.7%
EBITDA Margin - 3 Yr. Avg. 16.3%
Operating Margin 7.6%
Oper. Margin - 3 Yr. Avg. 12.9%
Pre-Tax Margin 1.2%
Pre-Tax Margin - 3 Yr. Avg. 7.6%
Net Profit Margin 0.2%
Net Profit Margin - 3 Yr. Avg. 4.9%
Effective Tax Rate 87.9%
Eff/ Tax Rate - 3 Yr. Avg. 51.6%
Payout Ratio 0%

ACHC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the ACHC stock intrinsic value calculation we used $2836.316 million for the last fiscal year's total revenue generated by Acadia Healthcare. The default revenue input number comes from 0001 income statement of Acadia Healthcare. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our ACHC stock valuation model: a) initial revenue growth rate of 7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.7%, whose default value for ACHC is calculated based on our internal credit rating of Acadia Healthcare, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Acadia Healthcare.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of ACHC stock the variable cost ratio is equal to 34.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1482 million in the base year in the intrinsic value calculation for ACHC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Acadia Healthcare.

Corporate tax rate of 27% is the nominal tax rate for Acadia Healthcare. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the ACHC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for ACHC are equal to 150.8%.

Life of production assets of 39.7 years is the average useful life of capital assets used in Acadia Healthcare operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for ACHC is equal to 2.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2572.871 million for Acadia Healthcare - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 88.235 million for Acadia Healthcare is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Acadia Healthcare at the current share price and the inputted number of shares is $3.2 billion.

RELATED COMPANIES Price Int.Val. Rating
AAC AAC Holdings 2.44 7.98  hold
NHC National Healt 79.67 26.55  str.sell
UHS Universal Heal 127.85 135.61  hold
DVCR Diversicare He 4.50 4.30  sell
ENSG Ensign Group 45.46 13.49  str.sell
CSU Capital Senior 7.51 0.65  str.sell

COMPANY NEWS

▶ Amid buyout reports, Acadia could close some U.K. facilities   [03:36PM  American City Business Journals]
▶ Acadia Healthcare: 3Q Earnings Snapshot   [05:16PM  Associated Press]
▶ KKR expected to outbid Bain, TPG in race for Acadia   [12:08PM  American City Business Journals]
▶ LifePoint shareholders OK merger, reject $120M in payments to execs   [Oct-29-18 03:34PM  American City Business Journals]
▶ Nashville company proposes $21M hospital in Cincinnati   [03:40PM  American City Business Journals]
▶ $21M hospital proposed for former Mercy Health site   [01:47PM  American City Business Journals]
▶ One of Nashville's newest health care companies is expanding   [Oct-22-18 03:54PM  American City Business Journals]
▶ Why Are Buyout Firms Ready to Risk It on Acadia?   [Oct-18-18 02:02PM  Bloomberg]
▶ TriStar names CEO for new behavioral health facility   [Oct-17-18 12:22PM  American City Business Journals]
▶ London tech company launches Nashville office   [Sep-21-18 03:27PM  American City Business Journals]
▶ Acadia's shares dip following lowered projections   [Jul-31-18 02:33PM  American City Business Journals]
▶ Acadia Healthcare: 2Q Earnings Snapshot   [Jul-30-18 05:09PM  Associated Press]
▶ 3 Top Healthcare Stocks to Buy in June   [Jun-15-18 10:21AM  Motley Fool]
▶ Addiction treatment company previously based in Mass. raises $25M   [May-30-18 03:46PM  American City Business Journals]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.